{"id":"W2057039211","doi":"10.3747/co.22.2430","title":"Management of egfr tki—Induced Dermatologic Adverse Events","year":2015,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Lakeridge Health; BC Cancer Agency; Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"Johnson and Johnson; Janssen Biotech; Astellas Pharma; AstraZeneca; Celgene; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Paronychia; Adverse effect; Dermatology; Gefitinib; Rash; Erlotinib; Epidermal growth factor receptor; EGFR inhibitors; Lung cancer; Clinical trial; Chemotherapy; Cancer; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001355596,0.0003182709,0.001847588,0.0002000525,0.00003188015,0.000001114297,0.0001616795,0.000260994,0.0001201341],"category_scores_gemma":[0.00001380805,0.0002251628,0.0004019128,0.0002519972,0.0000477988,0.00002861522,0.0001155361,0.0002730344,0.000249509],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001129732,"about_ca_system_score_gemma":0.001004986,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004369834,"about_ca_topic_score_gemma":0.000001399568,"domain_scores_codex":[0.9983711,0.0001322771,0.0006431608,0.0003542322,0.0002307772,0.0002684749],"domain_scores_gemma":[0.9987442,0.00004256146,0.0004945557,0.000398881,0.0001410176,0.0001787594],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000136439,0.0008455697,0.00008399739,0.02023624,0.0009667141,0.0001811409,0.00006295322,1.144835e-7,1.872039e-8,0.0003902464,0.003538126,0.9736812],"study_design_scores_gemma":[0.001720065,0.0003483449,0.00004914054,0.008763202,0.009061677,0.000169783,0.00008538108,0.000001036811,2.430195e-7,0.00008656287,0.9795613,0.0001532763],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000591574,0.9779943,0.00001425231,0.00007603498,0.002030004,0.001833127,0.00005247675,0.00004025381,0.01790046],"genre_scores_gemma":[0.00009434589,0.9977039,0.000356748,0.00002230621,0.0001122793,0.0004375982,0.0005928148,0.00003056781,0.0006494643],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9760231,"threshold_uncertainty_score":0.9181874,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.265417522412585,"score_gpt":0.5492822625137567,"score_spread":0.2838647401011716,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}